Cdt Equity Inc (CDT) - News Archive

In an era where technology and medicine increasingly intersect, Conduit Pharmaceuticals stands at the forefront, leveraging innovative technologies to push the boundaries of drug development. This burgeoning biopharmace...

Conduit Pharmaceuticals, a biotechnology company focused on drug development, has announced a strategic partnership aimed at utilizing artificial intelligence (AI) and cybernetics to modernize the processes involved in...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a biopharmaceutical company operating both in San Diego and London, has made strategic financial maneuvers to enhance its fiscal health and liquidity. With an aim to invigorat...

In an exciting development for the biopharmaceutical sector, Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a company at the forefront of innovative drug development, has announced its participation in the prestigious H.C....

Leveraging Innovation: Conduit Pharmaceuticals Pioneers Groundbreaking Autoimmune Disorder Therapies with Lead Clinical Candidate Selection The relentless rise of autoimmune disorders has spurred immense research and de...

Conduit Pharmaceuticals, a burgeoning player in the pharmaceutical industry, has recently announced a landmark exclusive licensing agreement with AstraZeneca. This significant partnership, finalized on Date, grants Cond...

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe s Leading Life Sciences HubSAN DIEGO and LONDON, March 11, 2024 - Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (Conduit Pharmaceuticals or Cond...